SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Autoimmunity/Immune-system caused problems
An SI Board Since February 2008
Posts SubjectMarks Bans
35 14 0
Emcee:  tnsaf Type:  Moderated
Introduction Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
10Public release date: 30-Jun-2008 Contact: Adam Cohen adam-cohen@omrf.org 405-27Ian@SI-7/1/2008
9<b>'HiCy' drug regimen reverses MS symptoms in selected patients&lidos-6/11/2008
8<b>FDA probes cancer in children given arthritis drugs</b> reuters.idos-6/5/2008
7<b>New Approach to Treating Autoimmune Disease</b> wis-wander.weizmidos-6/3/2008
6Abstract Title: Development and Characterization of a Clear, Mixed Micellar Formteevee-4/25/2008
5this drug should be good news for people who suffer from RA too: Researchers fiteevee-4/18/2008
4Slightly better MS news: fiercebiotech.comtommysdad-4/16/2008
3DNA's Rituxan Flunks MS Trial Adam Feurestein thestreet.com Rituxan is an intnsaf-4/15/2008
2<b>Autoantibodies and neuropsychiatric events in lupus</b> eurekaleidos-2/28/2008
1Fetal Hox11 expression patterns predict defective target organs: a novel link betnsaf-2/27/2008
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News